Clinical Trials Logo

Clinical Trial Summary

A prospective randomised controlled study to evaluate outcomes of the treatment with pradaxa or warfarin for prevention of recurrent DVT in patients with angiographically confirmed acute massive pulmonary embolism undergoIng endovascular mechanical fragmentation and thrombolytic therapy. [RE-SPIRE study]


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Angiographically Confirmed Acute Massive Pulmonary Embolism Treated With Endovascular Mechanical Fragmentation and Thrombolytic Therapy
  • Embolism
  • Pulmonary Embolism

NCT number NCT02979561
Study type Interventional
Source Meshalkin Research Institute of Pathology of Circulation
Contact Andrey Karpenko, MD\PhD
Email a_karpenko@meshalkin.ru
Status Recruiting
Phase Phase 4
Start date October 2016
Completion date June 2018